Symptomatic periesophageal vagal nerve injury by different energy sources during atrial fibrillation ablation.

atrial fibrillation catheter ablation complication gastric hypomotility pulmonary vein isolation vagal nerve injury

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 16 08 2023
accepted: 18 10 2023
medline: 15 11 2023
pubmed: 15 11 2023
entrez: 15 11 2023
Statut: epublish

Résumé

Symptomatic gastric hypomotility (SGH) is a rare but major complication of atrial fibrillation (AF) ablation, but data on this are scarce. We compared the clinical course of SGH occurring with different energy sources. This multicenter study retrospectively collected the characteristics and clinical outcomes of patients with SGH after AF ablation. The data of 93 patients (67.0 ± 11.2 years, 68 men, 52 paroxysmal AF) with SGH after AF ablation were collected from 23 cardiovascular centers. Left atrial (LA) ablation sets included pulmonary vein isolation (PVI) alone, a PVI plus a roof-line, and an LA posterior wall isolation in 42 (45.2%), 11 (11.8%), and 40 (43.0%) patients, respectively. LA ablation was performed by radiofrequency ablation, cryoballoon ablation, or both in 38 (40.8%), 38 (40.8%), and 17 (18.3%) patients, respectively. SGH diagnoses were confirmed at 2 (1-4) days post-procedure, and 28 (30.1%) patients required re-hospitalizations. Fasting was required in 81 (92.0%) patients for 4 (2.5-5) days; the total hospitalization duration was 11 [7-19.8] days. After conservative treatment, symptoms disappeared in 22.3% of patients at 1 month, 48.9% at 2 months, 57.6% at 3 months, 84.6% at 6 months, and 89.7% at 12 months, however, one patient required surgery after radiofrequency ablation. Symptoms persisted for >1-year post-procedure in 7 patients. The outcomes were similar regardless of the energy source and LA lesion set. The clinical course of SGH was similar regardless of the energy source. The diagnosis was often delayed, and most recovered within 6 months, yet could persist for over 1 year in 10%.

Sections du résumé

Background UNASSIGNED
Symptomatic gastric hypomotility (SGH) is a rare but major complication of atrial fibrillation (AF) ablation, but data on this are scarce.
Objective UNASSIGNED
We compared the clinical course of SGH occurring with different energy sources.
Methods UNASSIGNED
This multicenter study retrospectively collected the characteristics and clinical outcomes of patients with SGH after AF ablation.
Results UNASSIGNED
The data of 93 patients (67.0 ± 11.2 years, 68 men, 52 paroxysmal AF) with SGH after AF ablation were collected from 23 cardiovascular centers. Left atrial (LA) ablation sets included pulmonary vein isolation (PVI) alone, a PVI plus a roof-line, and an LA posterior wall isolation in 42 (45.2%), 11 (11.8%), and 40 (43.0%) patients, respectively. LA ablation was performed by radiofrequency ablation, cryoballoon ablation, or both in 38 (40.8%), 38 (40.8%), and 17 (18.3%) patients, respectively. SGH diagnoses were confirmed at 2 (1-4) days post-procedure, and 28 (30.1%) patients required re-hospitalizations. Fasting was required in 81 (92.0%) patients for 4 (2.5-5) days; the total hospitalization duration was 11 [7-19.8] days. After conservative treatment, symptoms disappeared in 22.3% of patients at 1 month, 48.9% at 2 months, 57.6% at 3 months, 84.6% at 6 months, and 89.7% at 12 months, however, one patient required surgery after radiofrequency ablation. Symptoms persisted for >1-year post-procedure in 7 patients. The outcomes were similar regardless of the energy source and LA lesion set.
Conclusions UNASSIGNED
The clinical course of SGH was similar regardless of the energy source. The diagnosis was often delayed, and most recovered within 6 months, yet could persist for over 1 year in 10%.

Identifiants

pubmed: 37965084
doi: 10.3389/fcvm.2023.1278603
pmc: PMC10642562
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1278603

Informations de copyright

© 2023 Miyazaki, Kobori, Jo, Keida, Yoshitani, Mukai, Sagawa, Asakawa, Sato, Yamao, Horie, Manita, Fukaya, Hayashi, Tanimoto, Iwayama, Chiba, Sato, Sekiguchi, Sugiura, Iwai, Isonaga, Miwa, Kato, Inaba, Hirota, Nagata, Ono, Hachiya, Yamauchi, Goya, Nitta, Tada and Sasano.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Références

Heart Rhythm O2. 2020 May 28;1(3):173-179
pubmed: 34113871
Heart Rhythm. 2017 May;14(5):670-677
pubmed: 28434448
J Cardiovasc Electrophysiol. 2013 Aug;24(8):847-51
pubmed: 23551640
J Cardiovasc Electrophysiol. 2022 Jun;33(6):1160-1166
pubmed: 35488745
Heart Rhythm. 2014 Oct;11(10):1779-84
pubmed: 24952149
Am J Cardiol. 2015 Jul 1;116(1):92-7
pubmed: 25933733
Heart Rhythm. 2015 Oct;12(10):2195-203
pubmed: 26031374
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):531-6
pubmed: 25772541
Heart Rhythm. 2014 Apr;11(4):574-8
pubmed: 24418167
J Arrhythm. 2021 Aug 28;37(5):1330-1336
pubmed: 34621432
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
Heart Rhythm. 2008 Sep;5(9):1327-30
pubmed: 18774112
J Am Coll Cardiol. 2005 Jul 19;46(2):327-30
pubmed: 16022963
J Am Heart Assoc. 2014 Sep 23;3(5):e001209
pubmed: 25249299
Pacing Clin Electrophysiol. 2018 Apr;41(4):389-395
pubmed: 29435991
Heart Rhythm. 2011 Jun;8(6):826-32
pubmed: 21315839
Int J Cardiol. 2021 Mar 1;326:103-108
pubmed: 33130261
J Cardiovasc Electrophysiol. 2014 Jan;25(1):1-7
pubmed: 24134539
J Cardiovasc Electrophysiol. 2016 Sep;27(9):1038-44
pubmed: 27221011
Circ Arrhythm Electrophysiol. 2023 Mar;16(3):e011605
pubmed: 36745559
Heart Rhythm. 2017 Oct;14(10):e445-e494
pubmed: 31631881

Auteurs

Shinsuke Miyazaki (S)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Atsushi Kobori (A)

Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.

Hikari Jo (H)

Department of Cardiology, National Hospital Organization Higashi-Hiroshima Medical Center, Hiroshima, Japan.

Takehiko Keida (T)

Department of Cardiology, Edogawa Hospital, Tokyo, Japan.

Kazuyasu Yoshitani (K)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.

Moe Mukai (M)

Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Yuichiro Sagawa (Y)

Department of Cardiology, Japanese Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.

Tetsuya Asakawa (T)

Department of Cardiology, Yamanashi Kosei Hospital, Yamanashi, Japan.

Eiji Sato (E)

Department of Cardiovascular Medicine, Sendai City Hospital, Miyagi, Japan.

Kazuya Yamao (K)

Department of Cardiology, Ome Municipal General Hospital, Tokyo, Japan.

Tomoki Horie (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Mamoru Manita (M)

Department of Cardiology, Naha City Hospital, Okinawa, Japan.

Hidehira Fukaya (H)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa, Japan.

Hidemori Hayashi (H)

Department of Cardiovascular Biology and Medicine, Juntendo University, Tokyo, Japan.

Kojiro Tanimoto (K)

Department of Cardiology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

Tadateru Iwayama (T)

Department of Cardiology, Okitama Public General Hospital, Yamagata, Japan.

Suguru Chiba (S)

Department of Cardiology, Urasoe General Hospital, Okinawa, Japan.

Akinori Sato (A)

Cardiovascular Center, Tachikawa General Hospital, Niigata, Japan.

Yukio Sekiguchi (Y)

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Kenta Sugiura (K)

Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.

Shinsuke Iwai (S)

Department of Cardiology, Hiratsuka Kyosai Hospital, Kanagawa, Japan.

Yuhei Isonaga (Y)

Department of Cardiology, Japanese Red Cross Saitama Hospital, Saitama, Japan.

Naoyuki Miwa (N)

Cardiovascular Center, Tsuchiura Kyodo Hospital, Ibaraki, Japan.

Nobutaka Kato (N)

Department of Cardiology, Hiratsuka Kyosai Hospital, Kanagawa, Japan.

Osamu Inaba (O)

Department of Cardiology, Japanese Red Cross Saitama Hospital, Saitama, Japan.

Takayoshi Hirota (T)

Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.

Yasutoshi Nagata (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Yuichi Ono (Y)

Department of Cardiology, Ome Municipal General Hospital, Tokyo, Japan.

Hitoshi Hachiya (H)

Cardiovascular Center, Tsuchiura Kyodo Hospital, Ibaraki, Japan.

Yasuteru Yamauchi (Y)

Department of Cardiology, Japanese Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.

Masahiko Goya (M)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Junichi Nitta (J)

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Hiroshi Tada (H)

Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Classifications MeSH